The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →CVS Caremark’s Zepbound exclusion was not permanent. The pharmacy benefit manager removed Eli Lilly’s medicine from its standard commercial formulary effective July 1, 2025, preferring Novo Nordisk’s Wegovy and Saxenda. CVS announced that Zepbound would return as an additional preferred option on its most common commercial formularies effective October 1, 2026. As of October 3, Lilly said coverage had been restored on select Caremark formularies—but that does not mean every Caremark member’s plan covers it.
For patients, employers and insurers, the practical question is the coverage and cost-sharing rules of a specific health plan, not simply whether CVS Caremark administers its pharmacy benefit. The episode also illustrates how formulary placement can shift as a pharmacy benefit manager negotiates with drugmakers, without revealing the confidential terms or proving which medicine is best for a particular patient.
What changed, and when?
The headline “CVS dropping Zepbound” describes the 2025 exclusion, not the latest announced status. CVS’s 2026 decision reversed that change for its most common commercial formularies, while leaving individual plan sponsors discretion to customize benefits.
| Date | What happened | What it means for coverage |
|---|---|---|
| May 1, 2025 | The Associated Press reported that Wegovy and Saxenda would become preferred on CVS Caremark’s standard formulary starting July 1, with Zepbound excluded. | Employers and insurers could customize coverage; not every plan necessarily adopted the standard formulary. |
| June 10, 2025 | Massachusetts’ Group Insurance Commission published guidance to its members about the upcoming change. | This described that state program’s handling of existing approvals and future requests under its plan rules. It was not a universal Caremark policy. |
| July 1, 2025 | The standard-formulary exclusion took effect. | The effect on a member depended on whether the plan sponsor adopted or modified the formulary and on the plan’s coverage terms. |
| May 28, 2026 | CVS announced Zepbound would return as an additional preferred option on its most common commercial formularies, effective October 1, 2026. | CVS said sponsors could still customize their coverage. |
| October 1, 2026 | The announced return date for Zepbound on those formularies. | It is not a guarantee of coverage for every Caremark member or plan. |
| October 3, 2026 | Lilly’s access page said coverage had been restored on select CVS Caremark formularies. | Lilly cautioned that coverage is not guaranteed and the plan administrator determines actual benefits. |
The Associated Press’s May 2025 account placed the preference change in the context of pharmacy benefit manager negotiations: preferred placement and negotiated discounts can influence which medicines appear on standard formularies, while employers and insurers may decide whether to customize them. Neither that reporting nor CVS’s public announcements disclose the private contract terms or rebate amounts behind these decisions.
#1 Best Overall
- Perfectly Fits 2 Zepbound & Mounjaro Injector Pens:Insulin pen cooler travel case is designed to hold up to 2 Zepbound&Mounjaro injector pens and also accommodates 2 EpiPens, meeting a variety of medication storage needs while on the go
- Reasonable Space Design:Diabetes travel case measures 9.06 × 3.94 × 2.17 inches, featuring a compact, travel-friendly design that can be easily held with one hand and fits neatly into a handbag or backpack. The smooth zipper and convenient carry handle make it easy to access and transport your medication wherever you go. Ideal for daily commuting, school, camping, outdoor activities, and short trips
- TSA-Approved Ice Packs :Includes 2x75g professional-grade gel ice packs filled with non-toxic, odorless, and colorless gel. They help keep Mounjaro & Zepbound injector pens cool for 6–8 hours. When frozen, the ice packs are TSA-friendly, making air travel easier and more convenient.You can place the medicine travel case in an easily accessible spot to speed up the security check proces
- Sturdy & Protective:Built with a scratch-resistant and wear-resistant exterior, mounjaro travel case features a thickened EVA interior and insulated aluminum foil lining to help lock in cold air and extend cooling performance. The hard-shell, pressure-resistant construction helps protect insulin pens, Mounjaro & Zepbound injector pens, and EpiPens from bumps, impacts, and daily wear. Even if accidentally dropped from a height, the case helps reduce the risk of damage to your medication
- Travel-Ready & Easy to Carry:Compact and lightweight,glp1 travel case tsa approved fits easily into a handbag, backpack, or luggage. Whether you're commuting, traveling, camping, or enjoying outdoor activities, it keeps your medication organized, protected, and within easy reach
What patients should check before relying on the change
“CVS Caremark” may identify the company administering a pharmacy benefit, but the employer, insurer, union or other plan sponsor generally determines the plan’s benefits. Lilly likewise says the plan administrator decides actual coverage. A formulary announcement is therefore a reason to check, not proof that a prescription is covered.
- Identify your exact plan. Use the member services number on your insurance card or the plan’s member portal. Ask whether your specific plan adopted the updated Caremark formulary or has its own version.
- Confirm the effective date and formulary status. Ask whether Zepbound is covered for your plan now, and whether it is preferred, nonpreferred or excluded. Do not assume that a general Caremark announcement applies to your plan.
- Ask about the rules and your likely cost. Confirm whether prior authorization is required, what eligibility criteria apply, what your cost sharing would be, and whether an exception or appeal process is available. CVS notes that access can involve prior authorization and that insurance coverage varies.
- Coordinate with your prescriber. If you may need to continue treatment, change medicines or request an exception, discuss the options with your clinician and plan. A formulary preference alone does not establish which treatment is clinically appropriate.
Separate insurance coverage from savings offers. Lilly’s access page lists a “starting at $25/month” statement for select CVS Caremark formularies, but the savings program is limited to eligible people, has exclusions and limits, and is not insurance. That figure is not a guaranteed price or a substitute for checking your plan’s benefit.
Rank #2
- GLP-1 Travel Case for Popular Pens: Designed for Zepbound, Mounjaro, Tirzepatide and similar injectable medication pens, this compact travel case keeps your essentials organized for work, errands, flights and short trips.
- EVA Hard Shell Protection: The durable hard shell helps protect pens from bumps, pressure and daily bag clutter, while the compact size fits easily in a purse, backpack, suitcase or carry-on.
- Neat Interior Storage: Elastic straps and a zippered pocket help separate pens, ice packs and small accessories such as alcohol pads or notes, so your medication travel kit stays easy to find and use.
- Neat Interior Storage: Elastic straps and a zippered pocket help separate pens, ice packs and small accessories such as alcohol pads or notes, so your medication travel kit stays easy to find and use.
- For Daily Use And Travel: Built for GLP-1, insulin and injectable medication travel needs, this insulated medicine travel case is a clean, reusable organizer for people who need a small cooler case outside the home.
CVS also announced a collaboration with Lilly intended to show eligible Zepbound and Foundayo patients reimbursed and self-pay options in the CVS app by early fourth quarter 2026. This is a company-announced offering, not proof that the feature is available to every patient as of October 4. Check the app and current terms before relying on it; a self-pay option is not the same as insurance coverage.
Why did CVS remove Zepbound, then bring it back?
In May 2026, CVS said it had negotiated with manufacturers to improve affordability while restoring choice. CVS Caremark President Ed DeVaney said, “We’re creating access and options that would not have existed without our leadership in the market.” CVS described manufacturer engagement and negotiations as the means of securing a more affordable cost for the added option. It has not publicly disclosed the relevant rebate amounts or contract terms, so those details—and a more specific account of the parties’ motives—cannot be established from the announcements.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Rank #3
- Perfectly Fits 2 Zepbound & Mounjaro Injector Pens:Insulin pen cooler travel case is designed to hold up to 2 Zepbound&Mounjaro injector pens and also accommodates 2 EpiPens, meeting a variety of medication storage needs while on the go
- Reasonable Space Design:Diabetes travel case measures 9.06 × 3.94 × 2.17 inches, featuring a compact, travel-friendly design that can be easily held with one hand and fits neatly into a handbag or backpack. The smooth zipper and convenient carry handle make it easy to access and transport your medication wherever you go. Ideal for daily commuting, school, camping, outdoor activities, and short trips
- TSA-Approved Ice Packs :Includes 2x75g professional-grade gel ice packs filled with non-toxic, odorless, and colorless gel. They help keep Mounjaro & Zepbound injector pens cool for 6–8 hours. When frozen, the ice packs are TSA-friendly, making air travel easier and more convenient.You can place the medicine travel case in an easily accessible spot to speed up the security check proces
- Sturdy & Protective:Built with a scratch-resistant and wear-resistant exterior, mounjaro travel case features a thickened EVA interior and insulated aluminum foil lining to help lock in cold air and extend cooling performance. The hard-shell, pressure-resistant construction helps protect insulin pens, Mounjaro & Zepbound injector pens, and EpiPens from bumps, impacts, and daily wear. Even if accidentally dropped from a height, the case helps reduce the risk of damage to your medication
- Travel-Ready & Easy to Carry:Compact and lightweight,glp1 travel case tsa approved fits easily into a handbag, backpack, or luggage. Whether you're commuting, traveling, camping, or enjoying outdoor activities, it keeps your medication organized, protected, and within easy reach
The 2025 preference for Wegovy and Saxenda, followed by Zepbound’s return as an additional preferred option, shows that preferred placement can change as commercial negotiations evolve. It does not show that formulary status determines clinical quality, or establish the revenue effect on Lilly or Novo Nordisk.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the shift can mean for employers and other payers
A preferred formulary gives a pharmacy benefit manager and plan sponsor a lever in negotiating drug costs. That can affect what a plan pays, but sponsors must also weigh member choice, clinical fit, treatment continuity and the rules that govern access. CVS’s 2026 announcement expressly leaves sponsors room to customize coverage, so employers should review their own plan terms rather than infer them from the template.
Rank #4
- 48-HOUR RELIABLE COOLING - Built with double-wall vacuum insulation, similar to premium thermal bottles. After comparing and screening 30+ bottle designs on the market, we chose this construction for its proven insulation performance and consistency. Helps keep your injector pens cool for up to 48 hours—perfect for long days out, travel, or anywhere you don’t have access to a fridge.
- COMPATIBLE WITH MOST GLP-1 INJECTOR PENS(HOLDS UP TO 4) - Designed to fit popular GLP-1 injector pens like Zepbound and Mounjaro. The roomy interior holds up to 4 pens in a staggered layout—giving you more storage without adding bulk.
- QUICK & EASY 3-STEP SETUP - Freeze the gel pack (6–8 hours), place them inside, and add your pens. That’s it. No cords, no complicated setup—just simple, dependable cooling whenever you need it.
- TOUGH OUTSIDE, PROTECTIVE INSIDE - The solid stainless steel shell helps shield your pens from bumps, pressure, and daily wear—much more durable than soft cooler bags that can collapse.
- DISCREET, TRAVEL-READY DESIGN - Looks like a regular bottle, not a medical case. Easy to carry in your backpack or carry-on, so you can travel with confidence and keep things low-key wherever you go.
CVS Caremark’s 2026 outlook gives a sense of the spending pressures it anticipates. These are CVS Caremark or CVS Health Analytics estimates, not universal forecasts for every plan:
| Caremark outlook figure | Scope and qualification |
|---|---|
| About 25% projected GLP-1 utilization growth | CVS Caremark / CVS Health Analytics estimate for 2026. |
| 30–40% of U.S. adults meet obesity criteria | Figure cited in Caremark’s 2026 outlook from its source notes; it is attributed to that report, not independently validated here. |
| About 15% decrease in net cost per prescription from 2025 to 2026 | CVS Health Analytics projection for commercial template-formulary clients with Standard Utilization Management. |
| About 10% increase in overall category spend | CVS Health Analytics projection for clients maintaining current benefit designs; CVS attributes the projected increase to higher utilization and expanded eligibility. |
Those projections illustrate why lower net cost per prescription can coexist with higher total spending: more use and broader eligibility can increase the number of prescriptions. They apply to the stated client groups and assumptions, not automatically to a particular employer, member or market.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Best Value
- Insulated Medication Travel Bag: This insulin travel case compact size, light weight but has full capacity to store your medical supplies. Easily fit into your luggage for journey, camping, traveling, or emergency kits. YOUSHARES diabetic cooler travel case to accompany you on your journey.
- Good Insulation: This Insulin cooler travel case is made of Oxford cloth material, Lined with double layer aluminum foil and insulating liner that provides a thermal insulating barrier, Diabetic travel case keep medicine cool while traveling.
- Cooler Travel Case TSA Approved: Gel Ice packs need to be refrigerated for 6 to 8 hours until frozen before use, Then put your Gel Ice packs, insulin pen, vial, or insulin needles into the designated compartment of the bag. Medical travel cooler keeps your diabetic insulin and many other temperature-sensitive medications cool for 4 to 6 hours.
- Medical Cooler Travel Bag: Ideal medicine travel cooler tsa approved for carrying medication diabetes pen or vials and insulin pen needles. Insulin pen travel case keep pocket, syringe, paper towel, consumables, or other simple accessories in a stable environment. This durable, attractive diabetic case travel case organizer is perfect for daily use.
- Package Include: 1 x insulin pen cooler travel case, 2 x reusable ice packs. YOUSHARES is dedicated to enhancing the convenience and happiness of individuals living with diabetes, empowering them to enjoy worry-free travels and daily activities.
What it signals for Lilly, Novo Nordisk and the drug market
The 2025 formulary preference favored Novo Nordisk’s Wegovy and Saxenda over Lilly’s Zepbound; CVS’s 2026 announcement added Zepbound back as a preferred option after negotiations it characterized as improving affordability. That sequence demonstrates that access for competing obesity medicines can shift with formulary decisions and manufacturer negotiations. It does not establish the undisclosed financial terms, the effect on either company’s sales, or a clinical comparison between the medicines.
The separate CVS-Lilly app collaboration concerns access to reimbursed and self-pay options for eligible patients. It should not be read as a promise that Zepbound is covered by a particular insurance plan or as a universal CVS cash price.
Medicare coverage is a separate pathway
The commercial Caremark formulary change should not be generalized to Medicare. CMS says the Medicare GLP-1 Bridge began making the Zepbound KwikPen formulation available to eligible beneficiaries on July 1, 2026. CMS describes a $50 copay and limits this Bridge pathway to use for weight management. Single-dose vial and single-dose pen formulations are excluded from the Bridge.
CMS says certain other medically covered uses are handled under Part D, with separate eligibility and exception rules. The Bridge and a commercial Caremark formulary are distinct coverage mechanisms; Medicare beneficiaries should verify the applicable CMS and plan rules for their situation.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
